Researchers at the Mayo Clinic in America have found that long-term prostate cancer survival rates for patients with an advanced stage of the disease suggest they can be good candidates for surgery. Their study found a 20-year cancer survival rate for 80 per cent of patients diagnosed with cancer that has potentially spread beyond the prostate, known as cT3 prostate cancer, and treated with radical prostatectomy, or surgery to remove the prostate gland. Previously, patients found to have cT3 prostate cancer were offered radiation or hormone treatment, but not radical prostatectomy.
The researchers presented their findings during the current American Urological Association Annual Meeting in Washington.
For information about the latest treatments for advanced prostate cancer and improved survival rates please click here for an article by Medical Oncologist, Professor Agamemnon Epenetos.
